Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $630,363 (100.0% shares, 0.0% debt)

Holdings (16)

AXSM AXSOME THERAPEUTICS INC 24.6%

Value ($000) $155,158 Shares 2,011,647 Est. Cost $45.81 Unrealized +30.5%

NUVL NUVALENT INC 13.2%

Value ($000) $83,056 Shares 2,788,981 Est. Cost $22.43 Unrealized +24.3%

— VERONA PHARMA PLC 11.9%

Value ($000) $75,137 Shares 2,875,526 Est. Cost $9.80 Unrealized —

ONC BEIGENE LTD 8.4%

Value ($000) $52,663 Shares 239,443 Est. Cost $198.98 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 6.3%

Value ($000) $40,007 Shares 1,369,623 Est. Cost $15.80 Unrealized +45.8%

NBIX NEUROCRINE BIOSCIENCES INC 5.4%

Value ($000) $33,802 Shares 283,000 Est. Cost $92.29 Unrealized +26.9%

COGT COGENT BIOSCIENCES INC 5.1%

Value ($000) $31,894 Shares 2,758,975 Est. Cost $9.18 Unrealized +35.0%

BCRX BIOCRYST PHARMACEUTICALS INC 4.6%

Value ($000) $29,195 Shares 2,543,107 Est. Cost $10.32 Unrealized +20.9%

— ASTRIA THERAPEUTICS INC 4.5%

Value ($000) $28,312 Shares 1,901,397 Est. Cost $11.99 Unrealized —

ARGX ARGENX SE 4.4%

Value ($000) $27,854 Shares 73,526 Est. Cost $266.01 Unrealized —

TERN TERNS PHARMACEUTICALS INC 3.3%

Value ($000) $20,767 Shares 2,040,000 Est. Cost $3.72 Unrealized +79.1%

ANNX ANNEXON INC 2.8%

Value ($000) $17,364 Shares 3,358,563 Est. Cost $4.53 Unrealized +21.2%

TRVI TREVI THERAPEUTICS INC 1.7%

Value ($000) $10,994 Shares 5,696,515 Est. Cost $3.04 Unrealized -35.3%

— DBV TECHNOLOGIES SA 1.7%

Value ($000) $10,809 Shares 7,064,964 Est. Cost $2.30 Unrealized —

TYRA TYRA BIOSCIENCES INC 1.7%

Value ($000) $10,769 Shares 1,416,998 Est. Cost $14.88 Unrealized -52.5%

— IMARA INC 0.4%

Value ($000) $2,582 Shares 631,333 Est. Cost $4.09 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	2,011,647	$155,158	24.6%	$45.81	+30.5%	COM	05464T104
NUVL	NUVALENT INC	2,788,981	$83,056	13.2%	$22.43	+24.3%	COM	670703107
—	VERONA PHARMA PLC	2,875,526	$75,137	11.9%	$9.80	—	SPONSORED ADS	925050106
ONC	BEIGENE LTD	239,443	$52,663	8.4%	$198.98	—	SPONSORED ADR	07725L102
VRDN	VIRIDIAN THERAPEUTICS INC	1,369,623	$40,007	6.3%	$15.80	+45.8%	COM	92790C104
NBIX	NEUROCRINE BIOSCIENCES INC	283,000	$33,802	5.4%	$92.29	+26.9%	COM	64125C109
COGT	COGENT BIOSCIENCES INC	2,758,975	$31,894	5.1%	$9.18	+35.0%	COM	19240Q201
BCRX	BIOCRYST PHARMACEUTICALS INC	2,543,107	$29,195	4.6%	$10.32	+20.9%	COM	09058V103
—	ASTRIA THERAPEUTICS INC	1,901,397	$28,312	4.5%	$11.99	—	COM	04635X102
ARGX	ARGENX SE	73,526	$27,854	4.4%	$266.01	—	SPONSORED ADR	04016X101
TERN	TERNS PHARMACEUTICALS INC	2,040,000	$20,767	3.3%	$3.72	+79.1%	COM	880881107
ANNX	ANNEXON INC	3,358,563	$17,364	2.8%	$4.53	+21.2%	COM	03589W102
TRVI	TREVI THERAPEUTICS INC	5,696,515	$10,994	1.7%	$3.04	-35.3%	COM	89532M101
—	DBV TECHNOLOGIES SA	7,064,964	$10,809	1.7%	$2.30	—	SPONSORED ADR	23306J101
TYRA	TYRA BIOSCIENCES INC	1,416,998	$10,769	1.7%	$14.88	-52.5%	COM	90240B106
—	IMARA INC	631,333	$2,582	0.4%	$4.09	—	COM	45249V107